Strides Pharma Science secures FDA approval for Gabapentin tablets

Pallavi Madhiraju- March 6, 2024 0

In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. ... Read More

Bajaj Healthcare forges CDMO agreement with UK/EU clients for API supply

Pallavi Madhiraju- February 28, 2024 0

Bajaj Healthcare Ltd., a prominent figure in the pharmaceutical industry specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates, and Formulations, has announced a ... Read More

Lupin Limited announces satisfactory FDA inspection results for Mandideep facility

Pallavi Madhiraju- November 1, 2023 0

Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for ... Read More

Cambrex announces $425m acquisition of American CDMO Halo Pharma

pallavi123- July 25, 2018 0

Cambrex Corporation, a leading manufacturer of small molecules and generic Active Pharmaceutical Ingredients (APIs), has announced a strategic acquisition of Halo Pharma for $425 million. ... Read More